BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Update

BioSyent Inc. (OTCMKTS:BIOYF) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 300 shares, a drop of 76.9% from the February 28th total of 1,300 shares. Based on an average trading volume of 2,200 shares, the days-to-cover ratio is currently 0.1 days.

BioSyent Stock Performance

Shares of OTCMKTS BIOYF opened at $7.88 on Friday. The stock’s 50-day moving average is $7.72 and its two-hundred day moving average is $7.89. BioSyent has a 1-year low of $5.93 and a 1-year high of $8.90.

BioSyent Increases Dividend

The business also recently disclosed a dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, March 3rd were paid a dividend of $0.0347 per share. The ex-dividend date of this dividend was Friday, February 28th. This is an increase from BioSyent’s previous dividend of $0.03. This represents a yield of 1.77%.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.